Weekly Digests

2020

May

High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade

May 27, 2020

When it comes to improving cancer immunotherapy, finding strong biomarkers and finding novel targets are both key goals. In two papers recently published back-to-back in Nature Medicine, Yuen and Liu et al. and Schalper and Carleton et al. identify IL-8 (also known as CXCL8) both as a predictive biomarker of reduced clinical benefit...

Exhausted T cells come in many flavors

May 20, 2020

Aiming to improve clinical response to immunotherapy by better understanding the mechanisms behind the development of the heterogeneous population of exhausted CD8+ T cells (Tex), Beltra et al. extensively analyzed Tex cells in a chronic infection setting. The researchers identified four subsets with distinct transcriptional, epigenetic, and phenotypic features, as well as elucidated...

MDSCs play metabolic freeze tag with T cells

May 13, 2020

Suppressive myeloid cells, namely myeloid-derived suppressor cells (MDSCs), are known to appear in situations of chronic inflammation and cancer, where they suppress cytotoxic T cell responses. However, without an existing definitive marker for this immune subset, MDSCs can be difficult to study and target. In research recently published in Nature Immunology, Baumann et...

Engineering a safer, more potent IL-2

May 6, 2020

Recombinant human interleukin-2 (rhIL-2, aldesleukin) was approved decades ago for the treatment of cancer, and it induces long-lasting, sometimes complete responses in a subset of patients with metastatic melanoma or metastatic renal cell carcinoma. However, due to the risk of capillary leak syndrome and associated toxicities, the use of rhIL-2 treatment has been...

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.